Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4220 |  TIL Instil Bio, Inc. - Common Stock | 6.56 USD | -4.23% | -8.76% | -13.00% | -66.34% | 44.49 M USD | ||
| 4223 |  CALC CalciMedica, Inc. - Common Stock | 1.30 USD | -12.16% | -20.73% | -41.44% | -61.54% | 44.38 M USD | ||
| 4227 |  HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.91 USD | -1.09% | +2.25% | -5.21% | -49.72% | 44.23 M USD | ||
| 4239 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.04 USD | -2.86% | 0.00% | -8.93% | -48.74% | 42.91 M USD | ||
| 4255 |  VERU Veru Inc. - Common Stock | 2.42 USD | -1.63% | -3.59% | -3.97% | +1.26% | 41.26 M USD | ||
| 4258 |  LNAI Lunai Bioworks Inc. - Common Stock | 1.12 USD | +2.75% | -23.29% | -56.42% | -8.20% | 40.62 M USD | ||
| 4285 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 0.99 USD | +1.02% | -9.17% | -13.91% | -31.25% | 37.40 M USD | ||
| 4288 |  LITS Lite Strategy, Inc. - Common Stock | 1.22 USD | -3.94% | -16.44% | +22.00% | -58.08% | 37.10 M USD | ||
| 4309 |  EDSA Edesa Biotech, Inc. - Common Shares | 3.66 USD | -5.91% | -8.73% | -23.75% | +37.08% | 35.29 M USD | ||
| 4321 |  GRDX GridAI Technologies Corp. - Common Stock | 4.80 USD | +16.50% | +34.83% | +59.47% | +88.24% | 34.23 M USD | ||
| 4327 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.92 USD | -2.00% | -8.84% | +9.50% | -69.28% | 34.10 M USD | ||
| 4331 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.08 USD | 0.00% | -6.09% | -13.60% | +3.85% | 33.96 M USD | ||
| 4332 |  CVM Cel-Sci Corporation Common Stock | 1.93 USD | -9.39% | -9.81% | +24.52% | -62.52% | 33.95 M USD | ||
| 4339 |  NNVC NanoViricides, Inc. Common Stock | 1.31 USD | -9.03% | +4.80% | +25.96% | +29.70% | 33.44 M USD | ||
| 4342 |  ALGS Aligos Therapeutics, Inc. - Common stock | 5.31 USD | -0.19% | -7.17% | -1.30% | -45.76% | 33.12 M USD | ||
| 4365 |  NXTC NextCure, Inc. - Common Stock | 6.78 USD | +3.35% | +31.14% | -15.14% | -48.24% | 31.03 M USD | ||
| 4372 |  QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 USD | +9.88% | -2.78% | -2.13% | +1298.10% | 29.86 M USD | ||
| 4382 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.71 USD | -2.84% | +8.23% | -0.58% | -82.02% | 28.95 M USD | ||
| 4383 |  IGC IGC Pharma, Inc. Common Stock | 0.28 USD | 0.00% | 0.00% | 0.00% | +7.69% | 28.95 M USD | ||
| 4394 |  CNTX Context Therapeutics Inc. - Common Stock | 0.30 USD | -3.23% | -3.23% | -18.92% | -79.59% | 27.56 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |